Back
Preformed Line Products Vs. Corcept Therapeutics Industry Stock Comparison
Sell
49
PLPC
Preformed Line Products
Last Price:
$136.71
Seasonality Move:
3.93%
Buy
59
CORT
Corcept Therapeutics
Last Price:
$71.95
Seasonality Move:
7.25%
Sell
49
Preformed Line Products (PLPC)
is a Sell
Is Preformed Line Products a Buy, Sell or Hold?
-
The current Preformed Line Products [PLPC] share price is $138.10. The Score for PLPC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
PLPC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $73.23. The Score for CORT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLPC Stock Price Chart
What is Preformed Line Products's stock price today?
-
The Preformed Line Products share price today is $138.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLPC is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $73.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLPC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 49.97 | Sell |
| Chaikin Money Flow: | -1055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.06 - 143.08) | Sell |
| Bollinger Bands (100): | (127.47 - 143.57) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.45 | Buy |
| Relative Strength Index (14 RSI): | 55.2 | Buy |
| Chaikin Money Flow: | 657833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.83 - 83.03) | Buy |
| Bollinger Bands (100): | (52.22 - 71.58) | Buy |
PLPC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.38 | Buy |
| 20-day SMA: | 137.81 | Buy |
| 50-day SMA: | 137.34 | Buy |
| 200-day SMA: | 130.04 | Buy |
| 8-day EMA: | 137.92 | Buy |
| 20-day EMA: | 138.2 | Sell |
| 50-day EMA: | 137.68 | Buy |
| 200-day EMA: | 133.01 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.35 | Buy |
| 20-day SMA: | 71.62 | Buy |
| 50-day SMA: | 65.78 | Buy |
| 200-day SMA: | 51.96 | Buy |
| 8-day EMA: | 70.12 | Buy |
| 20-day EMA: | 65.61 | Buy |
| 50-day EMA: | 47.06 | Buy |
| 200-day EMA: | 17.02 | Buy |
Preformed Line Products Earnings Growth & PLPC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Preformed Line Products Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||